相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated INR in a COVID-19 patient after concomitant administration of favipiravir and warfarin: A case report
Masao Sekimoto et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2022)
Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase
Silvia Fernandez et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
The Pyrimidine Analog FNC Potently Inhibits the Replication of Multiple Enteroviruses
Na Xu et al.
JOURNAL OF VIROLOGY (2020)
A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle
Xuejie Chen et al.
BLOOD (2020)
A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot Study
Zhigang Ren et al.
ADVANCED SCIENCE (2020)
Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China
Ying Zou et al.
BIOSCIENCE TRENDS (2020)
Clinical Importance of Drug-Drug Interaction Between Warfarin and Prednisolone and Its Potential Mechanism in Relation to the Niemann-Pick C1-Like 1-Mediated Pathway
Sayo M. Ito et al.
CIRCULATION JOURNAL (2019)
Intestinal absorption mechanisms of 2′-deoxy-2′-β-fluoro-4′-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein
Yixian Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Application of Static Modeling in the Prediction of In Vivo Drug-Drug Interactions between Rivaroxaban and Antiarrhythmic Agents Based on In Vitro Inhibition Studies
Eleanor Jing Yi Cheong et al.
DRUG METABOLISM AND DISPOSITION (2017)
Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions
Tomas Kvasnicka et al.
CURRENT DRUG METABOLISM (2017)
Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism
Daniel M. Witt et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects
Kenneth Todd Moore et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Effects of Rivaroxaban on Platelet Activation and Platelet-Coagulation Pathway Interaction: In Vitro and In Vivo Studies
Elisabeth Perzborn et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2015)
10-MINUTE CONSULTATION High INR on warfarin
Udaya Reddy et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
10-MINUTE CONSULTATION High INR on warfarin
Udaya Reddy et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban
Wolfgang Mueck et al.
CLINICAL PHARMACOKINETICS (2014)
Quantification of 2′-deoxy-2′-β-fluoro-4′-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies
Youmei Peng et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects
Wolfgang Mueck et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
Arlene M. Gallagher et al.
THROMBOSIS AND HAEMOSTASIS (2011)
The Design, Synthesis, and Antiviral Activity of Monofluoro and Difluoro Analogues of 4′-Azidocytidine against Hepatitis C Virus Replication: The Discovery of 4′-Azido-2′-deoxy-2′-fluorocytidine and 4′-Azido-2′-dideoxy-2′,2′-difluorocytidine
David B. Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis
Jeremie Sellam et al.
JOINT BONE SPINE (2007)
Proposal for a new tool to evaluate drug interaction cases
John R. Horn et al.
ANNALS OF PHARMACOTHERAPY (2007)
分享论文
